HOP-2A - Intratesticular Hormone Levels
HOP-2A
Intratesticular Hormone Levels in Healthy Young Men
1 other identifier
observational
10
1 country
1
Brief Summary
The purpose of this investigational study is to find out what hormones are present in healthy male testicles using fine needle aspiration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 18, 2008
CompletedFirst Posted
Study publicly available on registry
September 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedResults Posted
Study results publicly available
July 19, 2013
CompletedJune 13, 2016
May 1, 2016
4 months
September 18, 2008
November 8, 2010
May 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intratesticular Hormones in Normal Men
Average between right and left testis for each subject and serum hormone concentration in 10 normal men
6-weeks
Eligibility Criteria
Healthy males
You may qualify if:
- males between 18 and 50 years of age
- sperm count greater than 20 million/ml, greater than 50% motility, and greater than 15% normal morphology
- in good general health based on normal screening evaluation (consisting of a medical history, physical exam, normal sperm count, normal serum chemistry, hematology and baseline T, LH, and FSH levels)
- body mass index ≥18 and ≤32 kg/m2
- must agree not to participate in another research study involving drug exposure for the duration of the study
You may not qualify if:
- men in poor general health, with abnormal blood results
- sperm counts \<20 million/ml on two tests
- chronic, ongoing alcohol or drug abuse
- participation in a long-term male contraceptive study within the past three months
- history of testicular or scrotal surgery
- history of infertility
- abnormal testicular exam
- abnormal DRE
- chronic pain syndrome
- use of steroids, testosterone, or medications which might interfere with androgen metabolism including ketoconazole, glucocorticoids
- known bleeding disorder
- use of medications which may affect bleeding time (ongoing aspirin or anti-inflammatory use, coumadin)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Washington
Seattle, Washington, 98195, United States
Related Publications (8)
Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, Bremner WJ. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab. 2006 Nov;91(11):4374-80. doi: 10.1210/jc.2006-1411. Epub 2006 Aug 29.
PMID: 16940442BACKGROUNDAnawalt BD, Amory JK, Herbst KL, Coviello AD, Page ST, Bremner WJ, Matsumoto AM. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial. J Androl. 2005 May-Jun;26(3):405-13. doi: 10.2164/jandrol.04135.
PMID: 15867009BACKGROUNDCoviello AD, Bremner WJ, Matsumoto AM, Herbst KL, Amory JK, Anawalt BD, Yan X, Brown TR, Wright WW, Zirkin BR, Jarow JP. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. J Androl. 2004 Nov-Dec;25(6):931-8. doi: 10.1002/j.1939-4640.2004.tb03164.x.
PMID: 15477366BACKGROUNDCoviello AD, Matsumoto AM, Bremner WJ, Herbst KL, Amory JK, Anawalt BD, Sutton PR, Wright WW, Brown TR, Yan X, Zirkin BR, Jarow JP. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005 May;90(5):2595-602. doi: 10.1210/jc.2004-0802. Epub 2005 Feb 15.
PMID: 15713727BACKGROUNDPage ST, Kalhorn TF, Bremner WJ, Anawalt BD, Matsumoto AM, Amory JK. Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment. J Androl. 2007 Sep-Oct;28(5):734-41. doi: 10.2164/jandrol.107.002790. Epub 2007 May 9.
PMID: 17494097BACKGROUNDZhao M, Baker SD, Yan X, Zhao Y, Wright WW, Zirkin BR, Jarow JP. Simultaneous determination of steroid composition of human testicular fluid using liquid chromatography tandem mass spectrometry. Steroids. 2004 Oct-Nov;69(11-12):721-6. doi: 10.1016/j.steroids.2004.05.020.
PMID: 15579324BACKGROUNDKalhorn TF, Page ST, Howald WN, Mostaghel EA, Nelson PS. Analysis of testosterone and dihydrotestosterone from biological fluids as the oxime derivatives using high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2007;21(19):3200-6. doi: 10.1002/rcm.3205.
PMID: 17764104BACKGROUNDRoth MY, Lin K, Amory JK, Matsumoto AM, Anawalt BD, Snyder CN, Kalhorn TF, Bremner WJ, Page ST. Serum LH correlates highly with intratesticular steroid levels in normal men. J Androl. 2010 Mar-Apr;31(2):138-45. doi: 10.2164/jandrol.109.008391. Epub 2009 Sep 24.
PMID: 19779211RESULT
Biospecimen
serum blood, testicular tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Early termination of study leading to data analysis of the first ten of eleven men receiving aspirations.
Results Point of Contact
- Title
- Mara Roth, MD
- Organization
- University of Washington, Dept. of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
John K Amory, MD, MPH
University of Washington
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 18, 2008
First Posted
September 22, 2008
Study Start
September 1, 2008
Primary Completion
January 1, 2009
Study Completion
December 1, 2009
Last Updated
June 13, 2016
Results First Posted
July 19, 2013
Record last verified: 2016-05